Raymond James & Associates »

Arcutis Biotherapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $411k 41k 9.91